Global Lactoferrin Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Lactoferrin Market is presumed to reach the market size of nearly USD 689.65 Million by 2032 from USD 323.63 Million in 2023 with a CAGR of 8.77% under the study period 2024-2032.

Lactoferrin (LF), also identified as lactotransferrin, is a kind of multifunctional protein belonging to the transferring family. It is an iron-binding glycoprotein having a molecular mass of approximately 80 kDa. It is present in the milk of cows and human beings. The first milk that is produced after a baby's birth, known as colostrum, has seven times extra lactoferrin. It is also present in other bodily fluids like tears, saliva, secretion from the nose etc. Lactoferrin is both an antibacterial and antiviral and has immunological and anti-inflammatory properties. It improves iron deficiency, skin health, and immunity. Lactoferrin is used as a supplement and medicine.

MARKET DYNAMICS

The key factor driving the lactoferrin market is the increasing utilization of lactoferrin in a variety of applications. It is widely being used in infant formula, sports nutrition, food supplements, dietetic food, bakery items, non-alcoholic beverages etc. It helps to maintain infant health by building resistance power against infections in newborns. Increasing incidence of skin problems and increasing awareness about health and diet among the young generation will boost the market significantly. Furthermore, rising demand for lactoferrin from the Asia Pacific region will create significant growth opportunities for the lactoferrin market. However, lactoferrin may show some side effects if consumed in high doses, and this may hamper the growth of the lactoferrin market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Lactoferrin. The growth and trends of Lactoferrin industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Lactoferrin market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Function

Iron Absorption
Anti-inflammatory
Intestinal Flora Protection
Antibacterial
Immune Cell Stimulation
Antioxidant

By Application

Food & Beverages
Infant Formula
Sports & Functional Foods
Pharmaceuticals
Personal Care Products
Animal Feed

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Lactoferrin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Lactoferrin market include Hilmar Cheese Company, Pharming Group NV, FrieslandCamina, Synlait Milk Ltd., Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., Glanbia Plc, APS BioGroup, ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, InVitria, Milei GmbH, Ferrin-Tech LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215197

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. LACTOFERRIN - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Function
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL LACTOFERRIN MARKET ANALYSIS BY FUNCTION

5.1. Overview By Function
5.2. Historical and Forecast Data
5.3. Analysis By Function
5.4. Iron Absorption Historic and Forecast Sales By Regions
5.5. Anti-inflammatory Historic and Forecast Sales By Regions
5.6. Intestinal Flora Protection Historic and Forecast Sales By Regions
5.7. Antibacterial Historic and Forecast Sales By Regions
5.8. Immune Cell Stimulation Historic and Forecast Sales By Regions
5.9. Antioxidant Historic and Forecast Sales By Regions

6. GLOBAL LACTOFERRIN MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Food & Beverages Historic and Forecast Sales By Regions
6.5. Infant Formula Historic and Forecast Sales By Regions
6.6. Sports & Functional Foods Historic and Forecast Sales By Regions
6.7. Pharmaceuticals Historic and Forecast Sales By Regions
6.8. Personal Care Products Historic and Forecast Sales By Regions
6.9. Animal Feed Historic and Forecast Sales By Regions

7. GLOBAL LACTOFERRIN MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE LACTOFERRIN COMPANIES

8.1. Lactoferrin Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF LACTOFERRIN INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Hilmar Cheese Company
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Pharming Group NV
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. FrieslandCamina
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Synlait Milk Ltd.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Ingredia SA
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. MP Biomedicals
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Tatura Milk Industries Ltd.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Glanbia Plc
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. APS BioGroup
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. ProHealth
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Fonterra Cooperative Group Ltd.
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. Farbest Brands
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. InVitria
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. Milei GmbH
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Ferrin-Tech LLC
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies